Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether panitumumab in combination with
capecitabine/oxaliplatin are effective as first-line treatment in wild-type k-ras, metastatic
colorectal cancer patients.